Médicaments d’aide au sevrage tabagique

Mansourati, Jacques; Borel, M; Munier, Sevérine; Guevel-Jointret, A L

doi:10.1016/s0755-4982(05)84182-x

Cited by 6 publications

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients

et al. 2009

View full text Add to dashboard Cite

Both depression and smoking are highly prevalent and related to poorer outcomes in cardiac patients. In this study, the authors examined the association between depressive symptoms and smoking status, described the frequency and type of antidepressant use, and prospectively tested the effects of antidepressant use in smokers on smoking status and psychosocial outcomes. Participants comprised 1498 coronary artery disease (CAD) outpatients who completed a baseline survey which assessed depressive symptoms, current medications, and smoking status. A second survey was mailed 9 months later that assessed depressive symptoms, anxiety, insomnia, current medications and smoking status. Results showed that current and former-smokers had significantly greater depressive symptoms than non-smokers. Ten percent of patients were taking antidepressants, most frequently SSRIs, with significantly more smokers on antidepressants than former and non-smokers. At follow-up, smokers on antidepressants were less likely to have quit, had greater anxiety, depressive symptoms and insomnia than smokers not using antidepressants. This study demonstrated that smokers and quitters with CAD had greater depressive symptoms and use of antidepressants than non-smokers, but that the antidepressants utilized may not be optimizing outcomes.

show abstract